APPLICATION
ANDA073098
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
PEG-LYTEDiscontinued
POLYETHYLENE GLYCOL 3350 236GM/BOT, POTASSIUM CHLORIDE 2.97GM/BOT, SODIUM BICARBONATE 6.74GM/BOT, SODIUM CHLORIDE 5.86GM/BOT, SODIUM SULFATE ANHYDROUS 22.74GM/BOT · FOR SUSPENSION · ORAL
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.